The device, developed by a team of researchers led by Samuel K Sia, associate professor at Columbia University School of Engineering and Applied Science, can perform a point-of-care test that simultaneously detects three infectious disease markers.
The device replicates, for the first time, all mechanical, optical, and electronic functions of a lab-based blood test, researchers said.
The device performs an enzyme-linked immunosorbent assay (ELISA) without requiring any stored energy: all necessary power is drawn from the smartphone.
The accessory or dongle easily connects to a smartphone or computer and was recently piloted by health care workers in Rwanda who tested whole blood obtained via a finger prick from 96 patients who were enrolling into
Also Read
"Our work shows that a full laboratory-quality immunoassay can be run on a smartphone accessory," said Sia.
"Coupling microfluidics with recent advances in consumer electronics can make certain lab-based diagnostics accessible to almost any population with access to smartphones. This kind of capability can transform how health care services are delivered around the world," he said.
Sia estimates the dongle will have a manufacturing cost of USD 34, much lower than the USD 18,450 that typical ELISA equipment runs.
The team made two main innovations to the dongle to achieve low power consumption, a must in places that do not always have electricity.
The researchers eliminated the power-consuming electrical pump by using a "one-push vacuum," where a user mechanically activates a negative-pressure chamber to move a sequence of reagents pre-stored on a cassette.
Sia's team removed the need for a battery by using the audio jack for transmitting power and for data transmission. And, because audio jacks are standardised among smartphones, the dongle can be attached to any compatible smart device in a plug-and-play manner.
The research is published in the journal Science Translational Medicine.